Cargando…
New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
Receptor activator of nuclear factor κB (RANK) and its ligand (RANKL) play key roles in bone metabolism and the immune system. The RANK/RANKL complex has also been shown to be critical in the formation of mammary epithelia cells. The female hormones estradiol and progesterone closely control the act...
Autores principales: | Woźniczka, Magdalena, Błaszczak-Świątkiewicz, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588216/ https://www.ncbi.nlm.nih.gov/pubmed/34770897 http://dx.doi.org/10.3390/molecules26216491 |
Ejemplares similares
-
Antiprogestins in gynecological diseases
por: Goyeneche, Alicia A, et al.
Publicado: (2015) -
Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs)
por: Chwalisz, Kristof, et al.
Publicado: (2006) -
New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity
por: Błaszczak-Świątkiewicz, Katarzyna
Publicado: (2020) -
Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies
por: Wagenfeld, Andrea, et al.
Publicado: (2016) -
Antiproliferative Aspect of Benzimidazole Derivatives’ Activity and Their Impact on NF-κB Expression
por: Błaszczak-Świątkiewicz, Katarzyna
Publicado: (2019)